Operational conditions amplify soldier's constraints and stress factors, upsetting individual and collective adaptive landmarks. The soldier's resistance is strained by the high intensity of stressors, by the long duration of exposure and by their cumulative effect. This may lead to a state of "operational strain" that refers to chronic stress and the allostatic load imposed by operational constraint. The investigators believe that operational strain could manifest itself by a kind of accelerated aging of the organism due to the increased allostatic load without sufficient resource restoration (neurotransmitter precursors, partial and repeated sleep deprivation, etc.). This aging mechanism would be reversible after a sufficient period of resource restoration (sleep, physical activity, adapted diet, etc.).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
116
A blood sample will be collected before during and after the treatment.
The participants will be administered 4 capsules of L-Tyrosine 500 mg per oral route daily over 1 month.
The participants will fill in several psychological questionnaires before, during and after treatment administration: * Life Event Checklist * Moral injury * Posttraumatic Checklist * Burnout Assessment Tool * State-Trait Anger Expression Inventory-2 * Ruminative Response Scale - Reconsidered * Deployment Risk and Resilience Inventory-2 * Questionnaire about tobacco use
Photoplethysmography recording will be performed before during and after the treatment.
The participants will be administered 4 capsules of Lactose 500 mg (placebo) per oral route daily over 1 month.
Institut de Recherche Biomédicale des Armées
Brétigny-sur-Orge, France
Difference between the change in Burnout Assessment Tool (BAT) score following 1-month treatment in each arm
The Burnout Assessment Tool (BAT) is used to assess burn-out risk. The score ranges from 1 to 5, with higher scores indicating a higher risk of burn-out.
Time frame: After 1-month treatment
Difference between the change in catecholamine level following 1-month treatment in each arm
Catecholamine level will be measured in blood before during and after 1-month treatment.
Time frame: After 1-month treatment
Difference between the change in aminoacid level following 1-month treatment in each arm
Aminoacid level will be measured in blood before during and after 1-month treatment.
Time frame: After 1-month treatment
Difference between the change in zonulin level following 1-month treatment in each arm
Zonulin level will be measured in blood before during and after 1-month treatment.
Time frame: After 1-month treatment
Difference between the change in Brain-Derived Neurotrophic Factor (BDNF) level following 1-month treatment in each arm
BDNF level will be measured in blood before during and after 1-month treatment.
Time frame: After 1-month treatment
Difference between the change in gamma-aminobutyric acid (GABA) level following 1-month treatment in each arm
GABA level will be measured in blood before during and after 1-month treatment.
Time frame: After 1-month treatment
Difference between the change in Tumor Necrosis Factor Alpha (TNFα) level following 1-month treatment in each arm
TNFα level will be measured in blood before during and after 1-month treatment.
Time frame: After 1-month treatment
Difference between the change in Interleukin-6 (IL6) level following 1-month treatment in each arm
IL6 level will be measured in blood before during and after 1-month treatment.
Time frame: After 1-month treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.